Jena, Germany
NovaPump GmbH, founded in 2012, is at the forefront of medical device innovation in the Health Care sector. Headquartered in Germany, the company is pioneering with its "PERKAT" Perkutane Katheterpumptechnologie, a catheter-based heart pump system designed for rapid intervention in acute cardiac events such as heart attacks and cardiogenic shock.
Notable for its unique ability to function both pulsatile and self-expanding, NovaPump’s device offers a minimally invasive solution that can be swiftly deployed in catheterization labs. This novel technology has garnered significant attention and support, including funding from the German Ministry of Research.
During its Series A round in June 2020, NovaPump attracted investments from HTGF | High-Tech Gruenderfonds, bm-t beteiligungsmanagement thuringen, and Sparkasse Jena. As it aims to broaden its reach across numerous European heart centers, NovaPump presents a compelling opportunity in the medical device landscape.
